Erratum: Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval (Journal of the National Cancer Institute (2015) 107:11 (djv253) DOI:10.1093/jnci/djv253)

Denis L. Fontes Jardim, Maria Schwaederle, Maria Wei, J. Jack Lee, David S. Hong, Alexander M. Eggermont, Richard L. Schilsky, John Mendelsohn, Vladimir Lazar, Razelle Kurzrock

Research output: Contribution to journalComment/debate

Original languageEnglish
Article numberdjv423
JournalJournal of the National Cancer Institute
Volume108
Issue number2
DOIs
Publication statusPublished - 1 Feb 2016
Externally publishedYes

Cite this